Impact of dexamethasone responsiveness on long-term outcome in patients with newly diagnosed myeloma

被引：0
|
作者：
Sinha, S. [1 ]
Rajkumar, S. V. [1 ]
Lacy, M. [1 ]
Hayman, S. [1 ]
Baudi, F. [1 ]
Dispenzieri, A. [1 ]
Lust, J. [1 ]
Greipp, P. [1 ]
Gertz, M. [1 ]
Kumar, S. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8603
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution
    Franssen, Laurens E.
    Raymakers, Reinier A. P.
    Buijs, Arjan
    Schmitz, Marian F.
    van Dorp, Suzanne
    Mutis, Tuna
    Lokhorst, Henk M.
    van de Donk, Niels W. C. J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (05) : 479 - 488
  • [32] DEEP AND DURABLE RESPONSES WITH WEEKLY IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: LONG-TERM FOLLOW-UP OF PATIENTS WHO DID NOT UNDERGO SCT
    Kumar, S.
    Berdeja, J.
    Niesvizky, R.
    Lonial, S.
    Laubach, J.
    Hamadani, M.
    Stewart, A. K.
    Hari, P.
    Roy, V.
    Vescio, R.
    Kaufman, J.
    Berg, D.
    Liao, E.
    Rajkumar, V.
    Richardson, P.
    HAEMATOLOGICA, 2017, 102 : 142 - +
  • [33] Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients
    Fillitz M.
    Seebacher A.
    Panny M.
    memo - Magazine of European Medical Oncology, 2015, 8 (1) : 22 - 25
  • [34] Lenalidomide Induction and Maintenance Maximizes Outcome for Newly Diagnosed Transplant Eligible Myeloma Patients Irrespective of Risk Status: Long-Term Follow-up of the Myeloma XI Trial
    Jackson, Graham
    Pawlyn, Charlotte
    Cairns, David
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Russell, Nigel H.
    Jenner, Matthew
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Gregory, Walter M.
    Kaiser, Martin F.
    Davies, Faith E.
    Morgan, Gareth
    BLOOD, 2019, 134
  • [35] Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction
    Tamita, Koichi
    Katayama, Minako
    Takagi, Tsutomu
    Akasaka, Takashi
    Yamamuro, Atsushi
    Kaji, Shuichiro
    Morioka, Shigefumi
    Kihara, Yasuki
    CIRCULATION JOURNAL, 2007, 71 (06) : 834 - 841
  • [36] Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma
    Giaccone, Luisa
    Storer, Barry
    Patriarca, Francesca
    Rotta, Marcello
    Sorasio, Roberto
    Allione, Bernardino
    Carnevale-Schianca, Fabrizio
    Festuccia, Moreno
    Brunello, Lucia
    Omede, Paola
    Bringhen, Sara
    Aglietta, Massimo
    Levis, Alessandro
    Mordini, Nicola
    Gallamini, Andrea
    Fanin, Renato
    Massaia, Massimo
    Palumbo, Antonio
    Ciccone, Giovannino
    Storb, Rainer
    Gooley, Ted A.
    Boccadoro, Mario
    Bruno, Benedetto
    BLOOD, 2011, 117 (24) : 6721 - 6727
  • [37] Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma
    Schavgoulidze, Anais
    Lauwers-Cances, Valerie
    Perrot, Aurore
    Cazaubiel, Titouan
    Chretien, Marie-Lorraine
    Moreau, Philippe
    Facon, Thierry
    Leleu, Xavier
    Karlin, Lionel
    Stoppa, Anne-Marie
    Decaux, Olivier
    Belhadj, Karim
    Arnulf, Bertrand
    Mohty, Mohamad
    Mariette, Clara
    Fohrer-Sonntag, Cecile
    Lenain, Pascal
    Marolleau, Jean-Pierre
    Tiab, Mourad
    Araujo, Carla
    Orsini-Piocelle, Frederique
    Jaccard, Arnaud
    Roussel, Murielle
    Benboubker, Lotfi
    Eveillard, Jean-Richard
    Dib, Mamoun
    Divoux, Marion
    Attal, Michel
    Avet-Loiseau, Herve
    Corre, Jill
    HAEMATOLOGICA, 2023, 108 (05) : 1374 - 1384
  • [38] Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
    Kate Matthews
    Nature Clinical Practice Oncology, 2006, 3 (3): : 116 - 117
  • [39] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, Johnny
    O'Ceallaigh, Cathal
    Keane, Colm
    Otridge, Brian W.
    O'Gorman, Peter
    BLOOD, 2006, 108 (11) : 370B - 370B
  • [40] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, J
    Keane, C
    Otridge, BW
    Thornton, P
    O'Gorman, P
    BLOOD, 2005, 106 (11) : 380B - 380B
12345